About Sloning BioTechnology
Sloning BioTechnology is a company based in Puchheim (Germany) founded in 2001 was acquired by MorphoSys in October 2010.. Sloning BioTechnology has raised $11.86 million across 3 funding rounds from investors including MorphoSys, KfW and HBM Healthcare Investments. Sloning BioTechnology operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Puchheim, Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sloning BioTechnology
Sloning BioTechnology has successfully raised a total of $11.86M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(07 May 2003)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2009 | Amount | Series E - Sloning BioTechnology | Valuation | HBM Healthcare Investments , KfW |
|
| Nov, 2007 | Amount | Series E - Sloning BioTechnology | Valuation | KfW , DEWB | |
| May, 2003 | Amount | Series B - Sloning BioTechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sloning BioTechnology
Sloning BioTechnology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include MorphoSys, KfW and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location | |
|
Early-stage VC firm investing in smart & deep-tech, fin-tech and life science & health-tech sectors
|
Founded Year | Domain | Location | |
|
Investments in asset management and fintech are made by DEWB.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sloning BioTechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sloning BioTechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sloning Biotechnology Comparisons
Competitors of Sloning BioTechnology
Sloning BioTechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sloning Biotechnology
Frequently Asked Questions about Sloning BioTechnology
When was Sloning BioTechnology founded?
Sloning BioTechnology was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is Sloning BioTechnology located?
Sloning BioTechnology is headquartered in Puchheim, Germany. It is registered at Puchheim, Bavaria, Germany.
Is Sloning BioTechnology a funded company?
Sloning BioTechnology is a funded company, having raised a total of $11.86M across 3 funding rounds to date. The company's 1st funding round was a Series B of $4.91M, raised on May 07, 2003.
What does Sloning BioTechnology do?
Sloning Biotechnology has developed a patented technology platform to build protein libraries. Its patented Slonomics technology enables the precise construction of protein libraries comprising defined mixtures of amino acids at predetermined positions with speed. It claims that the technology opens the way to a new and flexible approach to generating optimized proteins, such as antibodies. In October 2010, it was acquired by MorphoSys.
Who are the top competitors of Sloning BioTechnology?
Sloning BioTechnology's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Sloning BioTechnology's investors?
Sloning BioTechnology has 5 investors. Key investors include MorphoSys, KfW, HBM Healthcare Investments, LBBW Venture Capital, and DEWB.